Defense Threat Reduction Agency – Chemical and Biological

UNCLASSIFIED
Defense Threat Reduction Agency – Chemical
and Biological Technologies
UNCLASSIFIED
UNCLASSIFIED
DTRA Mission
“To safeguard the US and its Allies from Weapons of Mass
Destruction (Chemical, Biological, Radiological, and Nuclear) and
High-Yield Explosives by providing capabilities to reduce,
eliminate and counter the threat, and mitigate its consequences”
Chemical
Biological
Radiological
Radiological
UNCLASSIFIED
Nuclear
Nuclear
High-Yield
Explosives
High-Yield
Explosives
UNCLASSIFIED
Evolution of Expertise and
Capabilities
DTRA’s lineage dates to
WWII “Manhattan Project”
•
•
•
•
•
Arms Control
Cooperative Threat Reduction
Countering WMD
Worldwide
Ops planning & readiness
R&D products & capabilities
US Government collaboration
COCOM execution
Nuclear Weapons Expertise
Combat Support
1998
CBDP
2003
Today
1942
UNCLASSIFIED
UNCLASSIFIED
DTRA and SCC-WMD Span the
National C-WMD Mission Areas
Across the three C-WMD missions areas, we support:
 Strategically (global and national)
 Operationally (theater)
 Tactically (battlefield)
We provide our expertise to:
 Strategy and Plans
 Operations
 Research and Development
UNCLASSIFIED
UNCLASSIFIED
DTRA Chemical and Biological
Technologies Dept – Mission
“To invest in transformational ideas, innovative people,
and actionable technology development for Chemical
and Biological Defense solutions”
Warfighter
Driven
Innovation
Driven
Strategy
Driven
Product Driven
MISSION
UNCLASSIFIED
Performance
Driven
Collaboration
Driven
Warfighter
Delivered
UNCLASSIFIED
Joint Science and Technology
(JSTO)
J9CB is the
Joint Science and
Technology Office
for the CBDP
UNCLASSIFIED
UNCLASSIFIED
Chemical and Biological Threats
• Chemical
– Traditional chemical warfare agents
• e.g., nerve agents, vesicants
– Toxic industrial materials and toxic industrial chemicals
– Emerging and non-traditional agents
• Biological
– Traditional biological threat agents
• e.g., anthrax, Ebola
– Emerging diseases
• e.g., pandemic flu, novel coronavirus
– Enhanced threats
• genetically engineered, especially virulent
UNCLASSIFIED
UNCLASSIFIED
J9-CB Portfolio
Addressing the Threat
Fieldable Sequencing
Vaccine Development
Standoff/Remote
Handheld Dx
Bio-ISR
CX partnership
Production
Testing
Distributed Point
Storage
Delivery
Release
Propagation
Wide Area Recovery
Exposure
Response
Recovery
BSVE
Elimination
Environmental Monitor
Exposure Monitor
Rapid CM Development
UNCLASSIFIED
UNCLASSIFIED
J9CB International S&T
Engagements
Poland: 1 Coalition Warfare
Project (through Army IEA)
Germany:
Participant in Army IEA
South Korea: 1 PA
Czech Republic:
1 PA , 1 active IEA
United Kingdom:
1 active IEA
Japan: 1 proposed IEA
Multilateral Engagement:
•
CBR Memorandum of Understanding (UK,
CAN, AUS)
•
NATO Joint CBRN Defense Capability
Development Group
•
Legacy activities under The Technical
Cooperation Program CBR Defense Group
(UK, CAN, AUS, NZ) include 3 active bilateral
Equipment and Material Transfer (E&MT)
Agreements
Singapore: 1 PA,
1 active IEA
Israel: 3 PAs; 1 PA in
development; 1 active IEA
India: 2 PAs; 1 PA in
development, 1 active IEA
Australia: 1 active IEA
Total: 8 Project Agreements (PAs), 6 Information Exchange Agreements (IEAs), 3 E&MTs, 3 agreements in development
•
Objective – Accelerate development of U.S. C-CBRNE capabilities by accessing
unique foreign S&T resources and sharing costs
•
S&T areas CBR Detection, Protection, Medical Countermeasures, and Modeling &
Simulation
UNCLASSIFIED
UNCLASSIFIED
Performers by State
VT - 1
RI - 1
12
2
1
1
1
38
1
2
8
12
15
2
2
32
11
5
1
14
2
4
25
10
AK
6
1
16
1
3
3
5
7
6
HI-1
UNCLASSIFIED
NH - 3
MA - 32
CT - 1
NJ - 3
DE -1
MD - 136
DC - 16
UNCLASSIFIED
JSTO – Core CBDP Capabilities
Sense/Shape
Diagnostics
Shield
Sustain
Prophylactics
Medical Diagnostics
Therapeutics
Chemical Prophylaxis
Chemical Therapeutics
Biological Prophylaxis
Biological Therapeutics
Radiological Prophylaxis
Radiological Therapeutics
Detection
Chemical Detection
Biological Detection
Protection
Hazard Mitigation
Radiological Detection
Respiratory & Ocular Protection
Personnel Contamination Mitigation
Expeditionary Analytics
Percutaneous Protection
Materiel Contamination Mitigation
Expeditionary Collective Protection
Information Management
CBRN Warning & Reporting
Operational Area
Capability Focus Area
ATDs
Anticipate Surprise
Decision Analysis & Management
Basic Research
Threat Agent Science
UNCLASSIFIED
Core Capability
Core Capability Not Being
Funded by the CBDP
Other
UNCLASSIFIED
FY14 Funding by Major Performer
% of S&T Funds
% of S&T Funds
16.5%
15.8%
14.6%
10.7%
10.9%
58.6%
16.1%
10.6%
2.2%
Service Labs
Industry
Academia
Other
USAMRIID
NRL
UNCLASSIFIED
ECBC
NATICK
2.8%
USAMRICD
Other
UNCLASSIFIED
Summary
• What do we do?
– Render CBRN threats ineffective through knowledge and
actionable, innovative technology
– Create technology products and knowledge through the
leadership of our Science and Technology Managers
– Team with stakeholders across an investment pipeline to
effectively translate and transition our products and knowledge
• How do we do what we do?
– Align with CBDP Strategy
• Investment in a strong foundation of knowledge creation and
translation
• Investments to deliver capability and technology to product
development
UNCLASSIFIED
UNCLASSIFIED
J9CB – Funding Opportunities
A. Annual JSTO
Program Build
1.
2.
3.
4.
5.
B. Fundamental
Research BAA
C – Innovation BAA
Go to www.fbo.gov
Select: Other Agency/Defense Threat Reduction Agency
Select Posted Date: Last 365 days or search by title (below)
Select ‘Search’
Find a relevant BAA for application (e.g.):
A. “HDTRA1-[year]-CHEM-BIO-BAA” – 1 solicitation per year
• TRL 1 to 5; JSTO specific; Contracts>OTAs (no grants)
B. “HDTRA1-09-[year]-FRCWMD-BAA” – 3 solicitations per year
• TRL 1 to 4; fundamental R&D; Grants>Contracts>OTAs>Misc.
C. “HDTRA1-11-[year]-RDIS-BAA” – Open Year Round
• TRL 2 to 5; innovative novel R&D; Contracts>Grants>Misc.
UNCLASSIFIED